PlantForm Corporation, PlantPraxis Biotecnologia and Bio-Manguinhos/Fiocruz (Health Ministry of Brazil) announced a collaborative research and development agreement to develop a biosimilar pembrolizumab for the Brazilian market.
"This agreement advances PlantForm's global strategy for biosimilar drug development and manufacturing to increase affordability and access to a wide range of life-saving medications." said Dr. Don Stewart, PlantForm's President and CEO.